The effectiveness comparison of Jitai tablets versus methadone in community-based drug treatment: A 1-year follow-up study

Addictive Behaviors

Volumn 38, Issue 10, 2013, Pages 2596-2600

  Hao, Shen Qiang ^a   Zhao, Min ^b   Zhang, Rui Wen ^c   Zhang, Jian Chen ^d   Zhang, Jing ^e   Feng, Xue Shan ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI MENTAL HEALTH CENTER   (China)

^c Shanghai Technological and Industrial Promotion Center of Traditional Chinese Medicine   (China)

^d Drug Control Office   (China)

^e Council of Shanghai Ziqiang Social Services ^*  (China)

Author keywords

Chinese medicine; Community based drug treatment; Jitai tablet; Methadone; Relapse prevention; Retention rate

Indexed keywords

CHINESE DRUG; ILLICIT DRUG; JITAI; METHADONE; NARCOTIC ANTAGONIST; UNCLASSIFIED DRUG;

APPETITE DISORDER; ARTICLE; BLURRED VISION; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; DIZZINESS; DRUG SAFETY; DRUG THERAPY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; OPIATE ADDICTION; RECURRENCE RISK; SOMNOLENCE; XEROSTOMIA;

CHINESE MEDICINE; COMMUNITY-BASED DRUG TREATMENT; JITAI TABLET; METHADONE; RELAPSE PREVENTION; RETENTION RATE;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; CHI-SQUARE DISTRIBUTION; CHINA; COHORT STUDIES; COMBINED MODALITY THERAPY; COMMUNITY HEALTH SERVICES; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; PATIENT COMPLIANCE; PRODUCT SURVEILLANCE, POSTMARKETING; RECURRENCE; SOCIAL SUPPORT; SURVIVAL ANALYSIS; TABLETS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84880336207     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2013.05.013     Document Type: Article

References (30)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders DSM-IV 1979, American Psychiatric Association, Washington (D. C.), (886 p.). 4th ed.
2. Bao Yugang, Zhang Yanhui Relative factors on heroin lapse of methadone maintenance treatment outpatients. Practical Preventive Medicine 2007, 14(6):1923-1925. (in Chinese).
3. Brandon T.H., Vidrine J.l, Litvin E.B. Relapse and relapse prevention. Annual Review of Clinical Psychology 2007, 3:257-284.
4. Chen Ang, Xia Yinghua, Chen Wen, Ling Li, Tan Wenkang, Zheng Rongjia Predictors of retention related factors at the initial methadone maintenance treatment clinics in Guangdong province. Chinese Journal of Epidemiology 2009, 30(12):1230-1233. (in Chinese).
5. Ciesla J.R. Evaluating the risk of relapse for adolescents treated for substance abuse. Addictive Disorders & Their Treatment 2010, 9(2):87-92.
6. Dole V.P., Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction: A clinical trial with methadone hydrochloride. JAMA: The Journal of the American Medical Association 1965, 193:80-84.
7. Dong Zhonglian, Wang Sufen, Zhou Lei Therapeutic effects of Jitai tablets combined with clonazepam and tramadol in the treatment of heroin addicts. Chinese Journal of Drug Dependence 2002, 11(2):131-132. (in Chinese).
8. Fareed, A., Vayalapalli, S., Stout, S., Casarella, J., Drexler, K., & Bailey, S. P. (2011). Effect of methadone maintenance treatment on heroin craving, a literature review. Journal of Addictive Diseases, 30(1), 27-38.
9. Friedman, David P. Drug addiction: A chronically relapsing brain disease. North Carolina Medical Journal 2009, 70(1):35-37.
10. Kayman D.J., Goldstein M.F., Deren S., Rosenblum A. Predicting treatment retention with a brief "opinions about methadone" scale. Journal of Psychoactive Drugs 2006, 38:93-100.
11. Kirshenbaum A.P., Olsen D.M., Bickel W.K. A quantitative review of the ubiquitous relapse curve. Journal of Substance Abuse Treatment 2009, 36:8-17.
12. Leshner A.I. Drug abuse and addiction treatment research: The next generation. Archives of General Psychiatry 1997, 54:691-694.
13. Li Xingli, Tan Hongzhuan, Sun Zhenqiu, Zhang Heng, Chen Mengshi, Ou Qiuying Study on the time of retention and related influencing factors of patients receiving methadone maintenance treatment in Hunan province. Chinese Journal of Epidemiology 2009, 30(7):672-675. (in Chinese).
14. Liang Tao, Liu Enwu, Zhong Hua, Wang Bing, Shen Limei, Wu Zhenglai Factors influencing the rate on reten- tion to methadone maintenance treatment program among heroin addicts in Guizhou, China. Chinese Journal of Epidemiology 2009, 30(2):131-135. (in Chinese).
15. Lu Ye, Gao Jingjing, Ni Min Analysis of relapse cases in heroin abusers. Chinese Journal of Drug Abuse Prevention and Treatment 2010, 17(1):27-31. (in Chinese).
16. Lu Sunan, Pan Lishan, Fang Li, Yin Ping, Ning Yaqing, Chen Lei Detoxification effect evaluation of JTT in the treatment of morphine dependent rats and monkeys. Chinese Journal of Drug Abuse Prevention 1998, (3):37-42. (in Chinese).
17. Marsch L.A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior, and criminality: A meta-analysis. Addiction 1998, 93:515-532.
18. Mattick R.P., Kimber J., Breen C., Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2008, 2:CD002207.
19. McKay J.R., Alterman A.I., Koppenhaver J.M., Mulvaney F.D., Bovasso G.B., Ward K. Continuous, categorical, and time to event cocaine use outcome variables: Degree of inter-correlation and sensitivity to treatment group differences. Drug and Alcohol Dependence 2001, 62(1):19-30.
20. McLellan A.T., Arndt I.O., Metzger D.S., Woody G.E., Obrien C.P. The effects of psychosocial services in substance abuse treatment. JAMA: The Journal of the American Medical Association 1993, 269:1953-1959.
21. McLellan A.T., Lewis D.C., O'Brien C.P., Kleber H.D. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and out-comes evaluation. JAMA: The Journal of the American Medical Association 2000, 284:1689-1695.
22. O'Brien C.P., McLellan A.T. Myths about the treatment of, addiction. Lancet 1996, 347:237-240.
23. Saunders B., Allsop S. Relapse: A psychological perspective. British Journal of Addiction 1987, 82(4):417-429.
24. Schwartz R.P., Kelly S.M., O'Grady K.E., Mitchell S.G., Peterson J.A., Reisinger H.S., et al. Attitudes toward buprenorphine and methadone among opioid-dependent individuals. American Journal on Addiction 2008, 17:396-401.
25. Sun Buqing, Ye Yugao, Qin Lingjun An analysis of relapse factors of 615 heroin addicts. Chinese Journal of Drug Dependence 2001, 10(3):214-216. (in Chinese).
26. Woody G.E., McLellan A.T., Luborsky L., Obrien C.P. Psychotherapy in community methadone programs: A validation study. The American Journal of Psychiatry 1995, 152(9):1302-1308.
27. Xiong Jianguo, Xiao Zaoxiang, Li Jun, Qin Desheng, Min Mingshan, Yang Jianhui, et al. Clinical effect of Jitai tablets com-bined with lofexidine in the treatment of heroin dependence. Chinese Journal of Drug Dependence 2001, 10(4):290-292. (in Chinese).
28. Xu Jinshui, Chen Guohong, Li Lei Retention and related factors of methadone treatment among drug users. Chinese Journal of Public Health 2009, 25(7):779-780. (in Chinese).
29. Xu Guozhu, Duan Lixia, Wang Zhefeng, Liu Ruike, Lu Xianxiang, Wang Zaixing, et al. A double-blind phase II clinical trial of Jitai tablets versus lofexidine in the treatment of heroin withdrawal symp-toms. Chinese Journal of Drug Dependence 2000, 9(4):273-277. (in Chinese).
30. Yang Yuecheng, Duan Song, Xiang Lifen, Ye Runhua, Gao Jie, Yang Shunsheng, et al. Adherence and related deter- minants on methadone maintenance treatment among heroin addicts in Dehong Prefecture, Yunnan province. Chinese Journal of Epidemiology 2011, 32(2):125-129. (in Chinese).